Home OncoMed moves forward on drug trials halted due to side effects
 

Keywords :   


OncoMed moves forward on drug trials halted due to side effects

2014-09-05 08:39:41| Chemicals - Topix.net

For the second time in a week, the Food and Drug Administration lifted a hold on three early-stage clinical trials of an experimental cancer-fighting drug by OncoMed Pharmaceuticals Inc. The studies are important for Redwood City-based OncoMed because partner Bayer HealthCare has the option under a 2010 deal to an exclusive license of the drugs after the trials are completed. Enrollment in both programs, halted in June , is expected to be under way again soon, OncoMed Chairman and CEO Paul Hastings said late Thursday afternoon.

Tags: due side forward effects

Category:Chemicals

Latest from this category

All news

02.07Chattanooga Area High School Students Graduate from BASFs TECH Academy
02.07Fayette Pipe Transforms Black Steel Pipe with FayetteGuard
02.07Automotive Coatings to Reach $19B by 2028: MarketsandMarkets
01.07Beckers Group Announces Leadership Changes
01.07BASFs TECH Academy Introduces Louisiana High School Students to Technical Careers
29.06Weekly Recap: PPG, Hempel, Beckers Group Top This Weeks Stories
28.06Jotun Launches CX-Rated Anticorrosive Powder Coating
28.06RPM to Announce Fiscal 2024 4Q, Year-End Results
Chemicals »
02.07Ansell Completes Acquisition of Kimberly-Clarks PPE Business
02.07Ecolab Launches 100% Plastic-Free Wipe for Healthcare Settings
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Chattanooga Area High School Students Graduate from BASFs TECH Academy
02.07Atlantic Tropical Weather Outlook
02.07Fayette Pipe Transforms Black Steel Pipe with FayetteGuard
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Public Advisory Number 16A
More »